From 2024 to 2028, the mortality rate of female breast malignant neoplasms in Brazil is forecasted to slightly increase from 23.2 to 23.7 deaths per 100,000 women, with a consistent year-on-year increase observed at 0.43% from 2024 to 2025, 0.43% from 2025 to 2026, 0.85% from 2026 to 2027, and 0.42% from 2027 to 2028. The compound annual growth rate (CAGR) over this period is approximately 0.56%.
Future trends to watch for include potential advancements in healthcare access and medical technologies, which may influence these mortality rates. Additionally, public health campaigns focusing on early detection and prevention could significantly impact these forecasts.
